XML 116 R101.htm IDEA: XBRL DOCUMENT v3.21.2
Interests in subsidiaries - Summary of interest in subsidiaries (Detail)
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Kazia Laboratories Pty Ltd [member]    
Disclosure of subsidiaries [line items]    
Principal place of business Australia  
Country of incorporation Australia  
Ownership interest 100.00% 100.00%
Kazia Research Pty Ltd [member]    
Disclosure of subsidiaries [line items]    
Principal place of business Australia  
Country of incorporation Australia  
Ownership interest 100.00% 100.00%
Kazia Therapeutics Inc [member]    
Disclosure of subsidiaries [line items]    
Principal place of business United States of America  
Country of incorporation United States of America  
Ownership interest 100.00% 100.00%
Glioblast Pty Ltd [member]    
Disclosure of subsidiaries [line items]    
Principal place of business Australia  
Country of incorporation Australia  
Ownership interest 100.00% 100.00%
Kazia Therapeutics (Hong Kong) Limited [Member]    
Disclosure of subsidiaries [line items]    
Principal place of business Hong Kong  
Country of incorporation Hong Kong  
Ownership interest 100.00%